Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
70%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
FHLC
334
HOLDINGS
20%
ALSO IN IXJ
IXJ
114
HOLDINGS
54%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.0% | 10.4% | 10.4% |
|
JOHNSON & JOHNSON | 7.5% | 7.1% | 7.1% |
|
ABBVIE INC | 6.1% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 4.0% | 3.7% | 3.7% |
|
UNITEDHEALTH GROUP INC | 4.5% | 3.1% | 3.1% |
FHLC Overweight Relative to IXJ
|
ELI LILLY & CO | 2.7% |
|
UNITEDHEALTH GROUP INC | 1.4% |
|
ABBVIE INC | 1.2% |
|
INTUITIVE SURGICAL INC | 0.9% |
|
ABBOTT LABORATORIES | 0.9% |
|
ALNYLAM PHARMACEUTICALS INC | 0.8% |
|
THERMO FISHER SCIENTIFIC INC | 0.8% |
|
BOSTON SCIENTIFIC CORP | 0.7% |
|
INSMED INC | 0.5% |
|
DANAHER CORP | 0.5% |
FHLC Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.6% |
|
NOVARTIS AG | -3.6% |
 |
NOVO NORDISK A/S-B | -1.8% |
|
GSK PLC | -1.5% |
 |
SANOFI-AVENTIS | -1.3% |
|
ESSILOR INTERNATIONAL | -1.1% |
 |
CSL LIMITED | -0.8% |
 |
HOYA CORP | -0.7% |
|
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |